Jiangsu Hengrui Medicine (600276.SS) Price/Sales Ratio
Market Cap: $293.53B
Avg Volume: 35.56M
Industry: Drug Manufacturers - General
Sector: Healthcare
What is Jiangsu Hengrui Medicine 's Price/Sales Ratio?
- Jiangsu Hengrui Medicine 's trailing twelve month (TTM) Price/Sales ratio is 11.32.
- Jiangsu Hengrui Medicine 's annual Price/Sales ratio as of today is 12.54.
- Jiangsu Hengrui Medicine 's quarterly Price/Sales ratio is 50.40.
What is the Price/Sales Ratio?
The Price/Sales ratio (P/S ratio) is a valuation metric that compares a company's stock price to its revenues. A lower P/S ratio may indicate that a stock is undervalued.
How is the Price/Sales Ratio calculated?
The Price/Sales ratio is calculated by dividing the company's market capitalization by its total sales or revenue. The formula is:
P/S Ratio = Market Capitalization / Total Sales (Revenue)
Related Metrics
Other important metrics to assess Jiangsu Hengrui Medicine 's financial health include:
- P/E Ratio (Price to Earnings Ratio) - measures the company's current share price relative to its per-share earnings:
- Annual: 66.51
- Quarterly: 69.89
- TTM: 53.88
- P/B Ratio (Price to Book Ratio) - compares the company's market value to its book value:
- Annual: 7.07
- Quarterly: 7.59
- TTM: 6.71
- P/C Ratio (Price to Cash Flow Ratio) - compares the company's market value to its cash flow:
- Annual: 37.44
- Quarterly: 212.80
- TTM: 36.90
- PEG Ratio (Price/Earnings to Growth Ratio) - measures the company's valuation considering its earnings growth:
- Annual: 5.80
- Quarterly: -1.72
- TTM: 45.26
These metrics provide insights into Jiangsu Hengrui Medicine 's financial health and its ability to meet short-term obligations. Comparing these ratios with industry benchmarks can offer a deeper understanding of the company's performance.
Annual Price/Sales Ratio
12.54
Quarterly Price/Sales Ratio
50.40
TTM Price/Sales Ratio
11.32
Jiangsu Hengrui Medicine Historical Price/Sales Ratio
Historical P/E Ratio
Historical P/B Ratio
Historical P/C Ratio
Historical PEG Ratio
Jiangsu Hengrui Medicine Historical Financial Metrics
The table below shows various financial metrics for each year, with the latest data available for the last fiscal year 2023.
| Year | Price/Sales Ratio | P/E Ratio | P/B Ratio | P/C Ratio | PEG Ratio |
|---|---|---|---|---|---|
| 2023 | 12.54 | 66.51 | 7.07 | 37.44 | 5.80 |
| 2022 | 11.53 | 62.80 | 6.49 | 193.89 | -4.46 |
| 2021 | 12.49 | 71.42 | 9.24 | 76.69 | -2.46 |
| 2020 | 21.29 | 93.29 | 19.35 | 172.02 | 4.90 |
| 2019 | 16.54 | 72.29 | 15.55 | 100.91 | 2.31 |
| 2018 | 11.20 | 47.97 | 9.89 | 70.31 | 1.71 |
| 2017 | 11.59 | 49.84 | 10.43 | 62.93 | 2.27 |
| 2016 | 8.02 | 34.35 | 7.18 | 34.30 | 1.67 |
| 2015 | 8.58 | 36.83 | 8.05 | 35.12 | 0.88 |
| 2014 | 5.24 | 25.74 | 4.92 | 24.78 | 1.29 |
Related Metrics
Explore detailed financial metrics and analysis for 600276.SS.